CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD)

Historical Holders from Q1 2019 to Q3 2025

Symbol
CRMD on Nasdaq
CUSIP
21900C308
Type / Class
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
Shares outstanding
74.9M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
34.2M
Holdings value
$421M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
170
Number of buys
111
Number of sells
-48
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SHAIBATALHAMD AYMEN ABDALKADER 6.2% $54.3M $54.3M 4.65M SHAIBATALHAMD AYMEN ABDALKADER Aug 8, 2025
BlackRock, Inc. 7.5% $31.2M 4.57M BlackRock, Inc. Dec 31, 2024

Institutional Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 240K $2.79M +$2.36M $11.63 5
2025 Q2 34.2M $421M +$143M $12.32 170
2025 Q1 23.7M $146M +$398K $6.16 135
2024 Q4 22.9M $185M +$29.9M $8.10 126
2024 Q3 19.1M $155M +$21.8M $8.08 100
2024 Q2 17.1M $74.2M -$748K $4.33 97
2024 Q1 17.3M $73.2M -$5.37M $4.24 89
2023 Q4 93.8K $353K +$270K $3.76 2
2023 Q3 17.9M $66.2M -$5.55M $3.70 92
2023 Q2 19.1M $75.5M +$32.9M $3.97 85
2023 Q1 10.7M $44.5M -$554K $4.14 63
2022 Q4 11.2M $46.9M +$1.43M $4.22 61
2022 Q3 10.9M $31.1M -$4.01M $2.83 64
2022 Q2 12.3M $49M -$6.78M $4.02 65
2022 Q1 13.4M $73.4M +$1.88M $5.48 83
2021 Q4 12.7M $58M +$6.44M $4.55 74
2021 Q3 11.8M $54.9M +$1.59M $4.65 77
2021 Q2 11.4M $77.9M +$3.07M $6.86 77
2021 Q1 10.8M $108M +$14.3M $9.99 76
2020 Q4 7.87M $58.5M +$6.7M $7.43 72
2020 Q3 7.04M $42.4M +$9.14M $6.03 69
2020 Q2 6.73M $42.4M +$1.36M $6.30 66
2020 Q1 6.56M $23.5M -$6.16M $3.59 53
2019 Q4 6.39M $46.5M +$380K $7.28 59
2019 Q3 6.37M $40.6M +$6.49M $6.38 52
2019 Q2 5.39M $48.3M +$15.5M $8.97 43
2019 Q1 3.66M $34.6M +$34.6M $9.45 41